BioLineRx Offers A Wide Range Of Potential Catalysts At An Affordable Valuation
- BioLineRx's current pipeline offers several undiscovered and promising stories.
- The stock is trading at a very low valuation compared to its peers.
- BioLineRx recently completed a secondary offering.
- BioLineRx has made a number of very positive announcement in the past three months.